157 related articles for article (PubMed ID: 19092123)
1. Nocturnal hemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells.
Chan CT; Liu PP; Arab S; Jamal N; Messner HA
J Am Soc Nephrol; 2009 Mar; 20(3):665-71. PubMed ID: 19092123
[TBL] [Abstract][Full Text] [Related]
2. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness.
Yuen D; Richardson RM; Fenton SS; McGrath-Chong ME; Chan CT
ASAIO J; 2005; 51(3):236-41. PubMed ID: 15968953
[TBL] [Abstract][Full Text] [Related]
3. The use of nocturnal home hemodialysis as salvage therapy for patients experiencing peritoneal dialysis failure.
Wong JH; Pierratos A; Oreopoulos DG; Mohammad R; Benjamin-Wong F; Chan CT
Perit Dial Int; 2007; 27(6):669-74. PubMed ID: 17984429
[TBL] [Abstract][Full Text] [Related]
4. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease.
Schwartz DI; Pierratos A; Richardson RM; Fenton SS; Chan CT
Clin Nephrol; 2005 Mar; 63(3):202-8. PubMed ID: 15786821
[TBL] [Abstract][Full Text] [Related]
5. The anemia of end-stage renal disease: hematopoietic progenitor cell response.
Segal GM; Eschbach JW; Egrie JC; Stueve T; Adamson JW
Kidney Int; 1988 May; 33(5):983-8. PubMed ID: 3392887
[TBL] [Abstract][Full Text] [Related]
6. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
[TBL] [Abstract][Full Text] [Related]
7. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
Shih LY; Huang JY
Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
9. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
11. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
Glaser M
Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
[TBL] [Abstract][Full Text] [Related]
12. Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
Tonelli M; Blake PG; Muirhead N
ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
[TBL] [Abstract][Full Text] [Related]
15. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
[TBL] [Abstract][Full Text] [Related]
16. Serum Erythropoietin levels and inhibitors of erythropoiesis in patients with chronic renal failure.
Fukushima Y; Fukuda M; Yoshida K; Yamaguchi A; Nakamoto Y; Miura AB; Harada T; Tsuchida S
Tohoku J Exp Med; 1986 Sep; 150(1):1-15. PubMed ID: 3775768
[TBL] [Abstract][Full Text] [Related]
17. Dual action of retinoic acid on human embryonic/fetal hematopoiesis: blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program.
Tocci A; Parolini I; Gabbianelli M; Testa U; Luchetti L; Samoggia P; Masella B; Russo G; Valtieri M; Peschle C
Blood; 1996 Oct; 88(8):2878-88. PubMed ID: 8874184
[TBL] [Abstract][Full Text] [Related]
18. Circulating burst-forming-unit erythroid and the responsiveness to recombinant human erythropoietin in patients on regular hemodialytic treatment.
Brunati C; Cappellini MD; De Feo T; Stefanoni I; Civati G; Ballerini L; Fiorelli G; Minetti L
Nephron; 1992; 62(2):150-4. PubMed ID: 1436306
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin activates a broad spectrum of progenitor cells.
Stockenhuber F; Kurz RW; Geissler K; Jahn C; Hinterberger W; Balcke P; Lechner K
Kidney Int; 1990 Jan; 37(1):150-6. PubMed ID: 2299802
[TBL] [Abstract][Full Text] [Related]
20. Erythroid progenitor cell kinetics in chronic haemodialysis patients responding to treatment with recombinant human erythropoietin.
Reid CD; Fidler J; Oliver DO; Cotes PM; Pippard MJ; Winearls CG
Br J Haematol; 1988 Nov; 70(3):375-80. PubMed ID: 3207631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
